The US market for Hemostats and Sealants resumed its growth in Q121 as procedures climbed back towards n...
The recovery in breast and hernia procedure stalled in Q420, with revenue dropping -9.2% YoY, according ...
The US market for Hemostats and Sealants continued back toward its pre-pandemic levels, gaining +20.0% Q...
The US market for Hemostats and Sealants began the journey back to normalcy, slipping -0.2% YoY in Q320,...
The US Surgical Matrices Market rebounded toward pre-COVID-19 levels in Q320 as the numbers of hernia an...
Headwinds increased in Q2 as COVID-19 shut down elective procedures and stay-at-home orders impacted tra...
The US Surgical Matrices Market collapsed in Q220, achieving sales of $227.3MM, off -39.4% YoY, as the e...
The US market for Hemostats and Sealants dropped precipitously by -32.4% YoY in Q220, as the effects of ...
The US Surgical Matrices Market treaded water in Q120, up +1.6%, as the impact of COVID-19 began to be f...
The US market for Hemostats and Sealants grew +6.1% YoY in Q120, up from the pace of Q419 despite the la...
Login